DTB: Rifaximin for the treatment of travellers' diarrhoea
Source: Drug and Therapeutics Bulletin (DTB)
Area: Evidence > Drug Specific Reviews
This review in the Drug and Therapeutics Bulletin (DTB) discusses the evidence for rifaximin and how it fits in with current management strategies for travellers' diarrhoea.
The review concludes that the evidence does not suggest benefit for rifaximin over existing standard treatments in the management of travellers' diarrhoea.
Source: NeLM - Drug Specific Reviews - Category: Drugs & Pharmacology Source Type: news